{
  "docId": "019de075-ba14-74ac-bf24-b9a07d855845",
  "docSlug": "ce85efab4cdfea0a9273e6eac7085298",
  "documentTitle": "MindMed | Investor Presentation Deck | 32 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 32,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "Includes chemical structures for drug candidates.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-ba14-74ac-bf24-b9a07d855845/3",
  "deckHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845",
  "deckJsonHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845.json",
  "deckAnchorHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "callout",
      "text": "Advancing Proprietary Drug Candidates Across Psychiatric Indications",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72b84ab2-aab6-4c02-ba75-74831ed9876e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.55,
        "y": 0.3
      },
      "kind": "list",
      "text": "MM-402: Autism Spectrum Disorder (ASD)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b327fe03-3f45-456f-8a16-447443e21ab9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.1,
        "y": 0.3
      },
      "kind": "list",
      "text": "MM-120: Generalized Anxiety Disorder (GAD) & Attention-Deficit/Hyperactivity Disorder (ADHD)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb9a26d4-59d0-47ed-8969-30673cb28ad8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.7,
        "x": 0.15,
        "y": 0.7
      },
      "kind": "list",
      "text": "Diversified pipeline of clinical programs targeting significant unmet medical needs; Pivotal inflection point with key clinical readout expected in Q4 2023; IP and R&D strategies intended to maximize market exclusivity and protection; Expected cash runway through key clinical readouts and into 2026",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c06ca1c2-c5ff-45bd-b6ff-669bc892589b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "paragraph",
      "text": "Using industry-leading drug development expertise to unlock the full therapeutic potential of psychedelics and other novel product candidates",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c96c5e5e-bdb4-46a1-8813-d868ff947305",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.1,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "1. The company's ending Q2 2023 cash and cash equivalents of $116.9 million and committed credit facility are expected to fund operations into 2026, if certain milestones are achieved that unlock additional capital",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af2252e4-b947-4aa1-914a-5aa075785580",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "MindMed at a Glance: A Global Leader in Brain Health",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "181feab7-cc8c-42ce-9705-d25cd43eb0bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.2,
        "x": 0.4,
        "y": 0.65
      },
      "kind": "title",
      "text": "Business Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d59a2983-ed33-43f8-bd07-96fcb07ad4c5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "acdb0742-b105-49fe-9226-a9ad892c3856",
      "evidence": "This slide is titled 'MindMed at a Glance: A Global Leader in Brain Health' and contains a list of bullet points and a paragraph summarizing the company's pipeline and goals.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ef05f44f-e58a-472e-8ce8-ca34828417f4",
      "evidence": "The deck presents MindMed's lead candidate and emerging treatment paradigm as a solution to the problem.",
      "position": 1,
      "objective": "Why is MindMed's approach necessary and effective?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}